Cargando…

Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients

BACKGROUND: Leptin is an hormone that regulates body weight. Studies have shown increasing leptin concentrations according to body mass index (BMI) and intermittent hypoxia. Our aim is to evaluate the basal leptin levels in OSA patients and its possible relation to OSA severity, independently of con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drummond, Marta, Winck, João C, Guimarães, João T, Santos, Ana C, Almeida, João, Marques, José A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567288/ https://www.ncbi.nlm.nih.gov/pubmed/18828917 http://dx.doi.org/10.1186/1471-2466-8-21

Ejemplares similares

Non-CPAP therapy for obstructive sleep apnoea
por: Verbraecken, Johan, et al.
Publicado: (2022)

Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol
por: Mineiro, Maria Alexandra, et al.
Publicado: (2016)

From CPAP to tailored therapy for obstructive sleep Apnoea
por: Sutherland, Kate, et al.
Publicado: (2018)

Treatment with CPAP in Elderly Patients with Obstructive Sleep Apnoea
por: Posadas, Tomas, et al.
Publicado: (2020)

Simultaneous sleep study and nasoendoscopic investigation in a patient with obstructive sleep apnoea syndrome refractory to continuous positive airway pressure: a case report
por: Loureiro, Claudia Chaves, et al.
Publicado: (2009)

Efficacy and patient satisfaction with autoadjusting CPAP with variable expiratory pressure vs standard CPAP: a two-night randomized crossover trial
por: Mulgrew, A. T., et al.
Publicado: (2006)

Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea
por: Wang, Tsai-Yu, et al.
Publicado: (2013)

Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment
por: Seetho, Ian W, et al.
Publicado: (2015)

Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
por: Peker, Yüksel, et al.
Publicado: (2017)

European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea
por: Randerath, Winfried, et al.
Publicado: (2021)

Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment
por: Xu, Pei-Hang, et al.
Publicado: (2023)

Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
por: Muñoz-Hernandez, Rocio, et al.
Publicado: (2015)

Mobile health application to support CPAP therapy in obstructive sleep apnoea: design, feasibility and perspectives
por: Suarez-Giron, Monique, et al.
Publicado: (2020)

A longitudinal study of CPAP therapy for patients with chronic cough and obstructive sleep apnoea
por: Sundar, Krishna M, et al.
Publicado: (2013)

P002 Targeted non-CPAP combination therapy resolves obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

Reversal of functional changes in the brain associated with obstructive sleep apnoea following 6 months of CPAP
por: Fatouleh, Rania H., et al.
Publicado: (2015)

Oral appliance treatment in moderate and severe obstructive sleep apnoea patients non‐adherent to CPAP
por: Gjerde, K., et al.
Publicado: (2015)

Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view
por: Craig, Sonya, et al.
Publicado: (2022)

P002 CPAP therapy compliance and changes in cognitive function in patients with obstructive sleep apnoea
por: Adams, R, et al.
Publicado: (2022)

Leptin, Obestatin and Apelin levels in patients with obstructive sleep apnoea syndrome
por: Zirlik, Sabine, et al.
Publicado: (2011)

The role of sleepiness on arterial stiffness improvement after CPAP therapy in males with obstructive sleep apnea: a prospective cohort study
por: Mineiro, Maria Alexandra, et al.
Publicado: (2017)

CPAP for secondary cardiovascular prevention in obstructive sleep apnoea patients: not only one moon, but many stars
por: Baillieul, Sébastien, et al.
Publicado: (2022)

P027 Predictors of CPAP failure in severe obstructive sleep apnoea and obesity hypoventilation syndrome patients
por: Chen, K, et al.
Publicado: (2022)

Prevalence and characteristics of sleep apnoea in patients with stable heart failure: Results from a heart failure clinic
por: Ferreira, Susana, et al.
Publicado: (2010)

Detecting COVID-19 and other respiratory infections in obstructive sleep apnoea patients through CPAP device telemonitoring
por: Pépin, Jean-Louis, et al.
Publicado: (2021)

Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database
por: van Zeller, Mafalda, et al.
Publicado: (2023)

High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations
por: Monneret, Denis
Publicado: (2022)

O030 Reduction in fall risk markers following CPAP treatment of obstructive sleep apnoea in people over 65 years
por: Stevens, D, et al.
Publicado: (2022)

Treatment-emergent central sleep apnoea after surgery for obstructive sleep apnoea
por: TESTANI, E., et al.
Publicado: (2018)

Snoring and obstructive sleep apnoea as risk factors in SARS-Cov-2: can nasal CPAP during sleep reduce pneumonia risk?
por: Sullivan, Colin E.
Publicado: (2020)

Effect of CPAP on cognitive function in stroke patients with obstructive sleep apnoea: a meta-analysis of randomised controlled trials
por: Yang, Yingxia, et al.
Publicado: (2023)

O013 The pathogenesis of obstructive sleep apnea in individuals with comorbid insomnia and obstructive sleep apnoea (COMISA)
por: Brooker, E, et al.
Publicado: (2021)

Obstructive sleep apnoea and anaesthesia
por: Rudra, A., et al.
Publicado: (2008)

Diagnosis of obstructive sleep apnoea
por: Raine, Richard
Publicado: (2019)

Mood, sleepiness, and weight gain after three years on CPAP therapy for sleep apnoea
por: Aro, Miia M., et al.
Publicado: (2021)

Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea
por: Justeau, Grégoire, et al.
Publicado: (2022)

Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis
por: Hecht, Lars, et al.
Publicado: (2011)

Treatment‐emergent central sleep apnoea managed by CPAP with adjunctive acetazolamide: A case report
por: Kwok, Chin Tong, et al.
Publicado: (2022)

Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
por: Palm, Andreas, et al.
Publicado: (2022)

The role of oral appliance therapy in obstructive sleep apnoea
por: Johal, Ama, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d56re54oboo1sttsrk306ka9ck